Related Experiment Video
Updated: May 14, 2026

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Preferences, Expectations and Management Satisfaction in IBD Patients: A Cross-Sectional Questionnaire-Based Study
Maja Mejza1, Anna Bajer1, Laura Biskup1
1Department of Digestive Tract Diseases, Medical University of Lodz, 90-153 Lodz, Poland.
Biological treatments improve life satisfaction and reduce disease activity in inflammatory bowel disease (IBD) patients. Discussing patient preferences and colorectal cancer screening is crucial for better outcomes.
Area of Science:
- Gastroenterology
- Clinical Medicine
- Patient-Reported Outcomes
Background:
- Rising global and Polish prevalence of Ulcerative Colitis and Crohn's Disease (Inflammatory Bowel Disease - IBD).
- Underexplored aspects of daily functioning and treatment in IBD patients.
- Need for comprehensive patient perspective in IBD management.
Purpose of the Study:
- To assess patient satisfaction with IBD treatment and its correlation with disease activity and life quality.
- To explore patient expectations and adherence to prescribed therapies.
- To identify factors influencing treatment satisfaction and outcomes in IBD.
Main Methods:
- Recruitment of adult IBD patients from the Medical University of Lodz, Poland.
- Data collection via a custom questionnaire on therapy opinions, expectations, and life satisfaction (June-July 2025).
- Analysis of 87 IBD patient responses correlating treatment type, disease activity, and outcomes.
Main Results:
- High overall treatment satisfaction (67.82%), linked to perceived respect for patient preferences.
- Biological therapy associated with higher satisfaction, lower disease activity, and fewer social limitations.
- Remission linked to less physical activity limitation; younger patients more likely to receive biologics.
- Higher surgical intervention rates in women; majority satisfied with surgical outcomes.
- Concerns regarding non-prescribed medication use (22.99%) and treatment regimen modification (24.14%).
- Significant fear of surgery (65.52%) but high satisfaction post-surgery (91.67%).
- Low adherence to colorectal cancer screening recommendations (10.81% for >8 years disease duration).
Conclusions:
- Biological treatments significantly improve IBD patient quality of life and reduce disease activity.
- Enhanced communication regarding patient preferences and shared decision-making is vital for gastroenterologists.
- Increased patient awareness and adherence to colorectal cancer screening protocols are necessary.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Assessment of the Gastrointestinal System II: Health Perception Pattern
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems related to...
Irritable Bowel Syndrome III: Medical and Nursing Management
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...